Bronchodilatory and anti-inflammatory effects of ASM-024, a nicotinic receptor ligand, developed for the treatment of asthma.

PLoS One · 2014 · PMC3899211 · PMID 24465890

Europe PMC DOI

hedged sentence

0.0020

closest p · 0.0× alpha

0.0020

boldest claim

The sentences

highly significantp < 0.002actually significant

Although the number of cells did not decrease to the levels found in control non-sensitized animals, the decrease was dose proportional and highly significant (p < 0.002) when compared to OVA-sensitized mice which did not receive ASM-024.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.